Midatech Pharma Plc | CIK:0001643918 | 3

  • Filed: 4/24/2018
  • Entity registrant name: Midatech Pharma Plc (CIK: 0001643918)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1643918/000121465918002960/0001214659-18-002960-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1643918/000121465918002960/mtph-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001643918
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfDeferredTaxesExplanatory

    23 Deferred tax

     

    Deferred tax is calculated in full on temporary differences under the liability method using tax rates applicable in the tax jurisdictions where the tax asset or liability would arise.

     

    The movement on the deferred tax account is as shown below:

     

        2017     2016     2015  
          £’000       £’000     £'000  
                           
    Liability at 1 January     -       6,547       354  
    Arising on business combination     -       -       6,191  
    Credited to income on impairment and amortisation of
    intangibles
        -       (5,509 )     -  
    Credited to income statement     -       (1,740 )     (131 )
    Foreign exchange gain     -       702       133  
                             
    Liability at 31 December     -       -       6,547  

     

    The movement on the deferred tax account in 2017 is Nil as the net credit arising on the amortisation of intangible assets and other timing differences has been matched by a reduction in the deferred tax asset recognised on the losses offsetting the liability remaining.

     

    A deferred tax liability has arisen due to deferred tax on intangible assets acquired in 2015.

     

    An intangible asset was impaired in the financial statements for the year ended 31 December 2016 by £11.4m which resulted in a £4.6m tax credit being recognised in the income statement.

     

    Unused tax losses carried forward, subject to agreement with local tax authorities, were as follows:

     

       

    Gross

    losses

     

        Unrecognised
    deferred tax
    asset
     
          £’000       £’000  
                     
    31 December 2015     23,286       4,191  
    31 December 2016     26,956       5,049  
    31 December 2017     38,377       6,639  

     

    With the exception of the £2.6m (2016: £3.7m: 2015: £1.6m) deferred tax asset which qualifies for offset against the deferred tax liabilities arising on the acquisitions of Midatech Pharma (Wales) Limited and Midatech Pharma US, the remaining potential deferred tax asset of £9.5m (2016: £8.1m) has not been provided in these accounts due to uncertainty as to the whether the asset would be recovered.

     

    Details of the deferred tax liability are as follows:

     

    2017   Asset     Liability     Net  
          £’000       £’000     £'000  
                           
    Business Combinations     2,599       (2,599 )     -  
                             
                             
    2016   Asset     Liability     Net  
          £’000       £’000     £'000  
                             
    Business Combinations     3,668       (3,668 )     -  
                             
                             
    2015   Asset     Liability     Net  
          £’000       £’000     £'000  
                             
    Business Combinations     1,625       (8,172 )     (6,547 )